Statistically significant improvement with ExoPTEN: ExoPTEN-treated eyes showed a statistically significant improvement in retinal response compared with injured eyes in the control group. This ...
Monthly recurring revenue (MRR) up 19.4% as of June 30, 2026; First-half turnover up 14.2% to €20.6 million; Strong improvement in earnings and positive free cash flow in the first half; Confirmation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results